SUBSCRIBE
SUBSCRIBE
News   Drug Development

Novartis AG’s Drug Onbrez Breezhaler Proved More Effective Against COPD than Other Drugs

September 20, 2010 | 
1 min read
ZURICH (Reuters) - Novartis' lung drug Onbrez Breezhaler allows patients with a deadly lung disease to breathe more easily than a current mainstay treatment, adding to positive sentiment surrounding the Swiss drugmaker.
Clinical research Postmarket research Europe
Novartis
MORE ON THIS TOPIC
Isolated hand photo on yellow background. Pink hand collage style. Bright pop art template with space for text. Creative minimalistic backdrop.
Lung cancer
Nuvation Scores First FDA Nod With Oral Lung Cancer Drug
June 12, 2025
 · 
2 min read
 · 
Tristan Manalac
Creative picture image collage banner of guy worker jump from financial charts determined company success.
Cardiovascular disease
Insmed ‘Blows Away Expectations’ With Positive Data for Inhaled Hypertension Therapy
June 11, 2025
 · 
2 min read
 · 
Tristan Manalac
Chalk drawing arrow turn or break through road block traffic pylon on dark blackboard using as obstacle, solution for business problem or break through to success concept.
Infectious disease
Gilead’s HIV Combo on Hold, With No Impact on FDA’s Pending Lenacapavir Decision
June 10, 2025
 · 
3 min read
 · 
Annalee Armstrong
Contemporary art collage. Conceptual design with young woman, motivated employee running forward to reach goal, professional success. Concept of business, career development, achievement
Neurodegenerative disease
Avidity’s siRNA Muscular Dystrophy Drug Improves Mobility, Boosts Muscle Strength
June 9, 2025
 · 
2 min read
 · 
Dan Samorodnitsky